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The nutrient sensor O-GlcNAc transferase modifies proteins with the O-GlcNAc moiety. In this
issue, Capotosti et al. (2011) reveal that O-GlcNAc transferase not only glycosylates the cell-cycle
regulator host cell factor 1 but activates it through proteolytic cleavage, providing a surprising link
between metabolism and epigenetic regulation of the cell cycle.Host cell factor 1 (HCF-1) is an evolution-
arily conserved epigenetic regulator that
undergoes an unusual proteolytic pro-
cessing event to generate stably associ-
ated fragments that regulate different
stages of the cell cycle (Kristie et al.,
2010). In vertebrates, the molecular iden-
tity of the factor responsible for HCF-1
cleavage has been cloaked in mystery.
With a plot twist worthy of a best-selling
detective novel, Capotosti et al. now
unmask an unexpected culprit—the
nutrient-sensing epigenetic regulator
O-linked GlcNAc transferase (OGT)
(Figure 1). Their findings provide com-
pelling evidence that OGT has a dual
enzymatic role, catalyzing both O-GlcNA-
cylation and cleavage of HCF-1. This part-
nering of two epigenetic regulators to
control cell-cycle progression has impor-
tant implications for fields as diverse as
viral pathogenesis, stem cell biology, and
diseases of aging including cancer, dia-
betes, and neurodegeneration.
Although the HCF-1 protein was origi-
nally identified as a target for the Herpes
simplex virus VP16 transcriptional acti-
vator, subsequent work has shown thatHCF-1 normally coordinates passage
through the cell cycle (Goto et al., 1997).
The N-terminal subunit, HCF-1N, pro-
motes progression through G1, whereas
the C-terminal subunit, HCF-1C, regulates
mitosis and cytokinesis. In vertebrates,
these domains are separated by six
conserved HCF-1PRO repeats, which
contain many proline and threonine resi-
dues and an invariant glutamate that
marks the site of proteolysis. Cleavage
at this site is required for HCF-1 regulation
of M phase events. Although HCF-1
activity in all animals is regulated by prote-
olysis, the HCF-1 sequence differs greatly
between invertebrates and vertebrates
such that different animal lineages employ
distinct mechanisms for HCF-1 process-
ing. Lower metazoans employ a threo-
nine-directed endopeptidase (taspase)
to sever the two HCF-1 subunits, but
vertebrates use a different strategy (Ca-
potosti et al., 2011).
Multiple pieces of evidence hint that
posttranslational modification of HCF-1
might be important for cleavage. Capo-
tosti et al. show that inhibitors of phos-
phorylation do not alter processing, buta presumptive OGT inhibitor and deple-
tion of OGT by RNA interference prevent
HCF-1 maturation. Although O-GlcNAcy-
lation of HCF-1 depends on the presence
of the threonine-rich HCF-1PRO repeats, it
is several threonines in the HCF-1N
N-terminal subunit that are glycosylated.
OGT does more than simply glycosylate
HCF-1 before it is cleaved. Capotosti
et al. show that OGT glycosylates and
then remains bound to a cleavage-resis-
tant HCF-1 mutant. Furthermore, they
find that purified recombinant OGT
cleaves the HCF-1PRO repeat in vitro.
The authors suggest thatO-GlcNAc-cata-
lyzed autoproteolysis of HCF-1 does not
efficiently cleave HCF-1PRO repeats
in vitro. Providing an in vivo validation of
this conclusion, the authors replace the
vertebrate HCF-1PRO domain with a tas-
pase cleavage site. Although this variant
is efficiently processed by taspase, it is
neither recognized nor cleaved by OGT,
and this heterologous HCF-1 does not
rescue HCF-1 function. Together, these
data strongly suggest that OGT-depen-
dent glycosylation and cleavage are
critical for the M phase functions of, February 4, 2011 ª2011 Elsevier Inc. 321
Figure 1. OGT GlcNAcylates and Cleaves HCF-1 for Cell-Cycle
Progression
O-GlcNAc transferase (OGT) couples the nutrient-dependent synthesis of
UDP-GlcNAc to the O-GlcNAcylation of numerous targets including the cell-
cycle regulator host cell factor 1 (HCF-1). OGT is also necessary and sufficient
for proteolysis of the HCF-1PRO domain; together O-GlcNAcylation and
cleavage of HCF-1 promote changes in chromatin organization that are
required for progression through G1-S and M phases of the cell cycle. OGT
and HCF-1 are tethered together in a tight complex and share a number of
known binding partners and targets, participating in chromatin remodeling and
cell-cycle regulation to influence stem cell fate, development, and disease-
related processes including immunity, cancer, diabetes, and neuro-
degeneration.HCF-1, building a compelling
case that OGT is the long-
sought HCF-1 protease
(Figure 1).
OGT contains no obvious
protease-like domains, so
how does it catalyze HCF-1
proteolysis? The authors
examine two possibilities.
OGT is part of an enzyme
superfamily with known
hydrolases as members, and
as such, it could retain cryptic
protease activity. Based on
similarities between the
OGT-mediated cleavage of
HCF-1PRO and the proteol-
ysis of E. coli LexA by its cop-
rotease, RexA, the authors
favor a model in which OGT
promotes a conformational
change in the HCF-1PRO
domain, repositioning the
cleavage site and the N-
terminal O-GlcNAc moieties
to stimulate hydrolysis (Ca-
potosti et al., 2011).
The recent finding that
OGT modulates cell-cycle
dynamics through its modifi-
cation and processing ofHCF-1 provides definitive support for
a growing body of evidence linking
O-GlcNAc to epigenetics and disease
(Hanover et al., 2010 and Love et al.,
2010b). O-GlcNAc is added to and
removed from proteins by separate
enzymes in a manner reminiscent of
dynamic phosphorylation. OGT couples
the nutrient-dependent synthesis of
UDP-GlcNAc to the O-GlcNAcylation of
Ser/Thr residues of a variety of targets.
This link between nutrient availability
and O-GlcNAcylation of proteins through
the hexosamine signaling pathway
provides cells with a mechanism to
sense and respond to a variety of envi-
ronmental conditions. Some of the
known O-GlcNAcylated proteins include
signaling kinases, nuclear pores compo-
nents, various chromatin-remodeling
enzymes, and RNA polymerase II. In
addition, one isoform of OGT is targeted
to mitochondria where it coordinates
apoptotic and metabolic functions by
adding O-GlcNAc to key mitochondrial
proteins (Hanover et al., 2010). The
O-GlcNAc moiety is removed by the322 Cell 144, February 4, 2011 ª2011 ElsevieO-GlcNAcase, MGEA5. Together the
enzymes of O-GlcNAc cycling balance
the activity of numerous kinases, influ-
encing the robustness of cell prolifera-
tion and tissue homeostasis decisions
(Butkinaree et al., 2010; Hanover et al.,
2010). Both OGT and MGEA5 have
been previously implicated in cell-cycle
progression (Wang et al., 2010) and
epigenetic regulation (Hanover et al.,
2010). In Drosophila, OGT is encoded
by the homeotic gene ‘‘Super sex
combs,’’ a gene previously linked to the
epigenetic regulation of the polycomb
and trithorax groups (Love et al.,
2010b). In C. elegans, mutations that
affect O-GlcNAc cycling provide insight
into the signaling cascades triggered
by stress, infection, and aging (Love
et al., 2010a). In vertebrates, OGT and
HCF-1 coexist in deacetylase and
methyltransferase chromatin-remodeling
complexes, providing yet another link
to epigenetic regulatory events (Wy-
socka et al., 2003).
The pairing of OGT with HCF-1 regu-
lates cell-cycle progression by placingr Inc.it under the control of
stress-triggered, nutrient-
responsive O-GlcNAcylation
and thus has profound impli-
cations for fields ranging
from viral pathogenesis and
stem cell biology to diseases
of aging. Viruses, like Herpes
simplex, notoriously subvert
the host cell-cycle machinery
for maintaining dormancy
and viral production (Kristie
et al., 2010). Integrating
both stress and nutrient
availability, host O-GlcNAcy-
lation is a likely regulator of
viral latency. Stem cell pluri-
potency and self-renewal
may also be regulated by
OGT and HCF-1 as both
are components of the
Oct4-centered transcription
factor network implicated in
stem cell pluripotency (Love
et al., 2010b). In adulthood,
obesity and nutrient excess
are associated with an
increased risk for diabetes,
cardiovascular disease, and
cancer; genome-wide asso-
ciation studies have linkedthe OGT and MGEA5 loci to these
same diseases (Hanover et al., 2010;
Butkinaree et al., 2010). The recently
uncovered connection between OGT
and HCF-1 provides an important clue
for understanding how the environmen-
tally responsive hexosamine-signaling
pathway intersects with human develop-
ment and disease, highlighting the
importance of the O-GlcNAc modifica-
tion in epigenetic regulation of cell prolif-
eration and signaling during develop-
ment, adulthood, and senescence.REFERENCES
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Caveolae are protein-driven membrane invaginations that regulate both the physical and chemical
composition of the plasma membrane. Sinha et al. (2011) now show that caveolae are membrane
reservoirs that are used to rapidly buffer against changes in membrane tension.The cell membrane exhibits fluid-like
mechanical properties and is subject to
a resting surface pressure that creates
a well-defined membrane tension (Evans
and Skalak, 1980). Although cellular
membrane tension primarily reflects the
adhesion of the membrane to the cyto-
skeleton (Sheetz, 2001), it is also affected
by tension in the lipid bilayer. The magni-
tude of bilayer tension affects the packing
of proteins and lipids in the membrane,
influencing their properties at the
molecular and supramolecular scale—for
instance, many mechanosensitive chan-
nels are gated by membrane tension
(Hua et al., 2010). It is therefore not
surprising that cells have evolved many
ways of regulating tension to withstand
changes in osmotic pressure, fluid shear,
or mechanical deformation. Most of the
mechanisms of compensation that have
been invoked to date involve adding or
taking away membrane through exo- or
endocytosis, which occur over relatively
slow timescales (Sheetz and Dai, 1996).
Flask-shaped membrane invaginations
known as caveolae have also been impli-
cated in the buffering against changes in
plasma membrane composition and
physical properties (Parton and Simons,
2007). In this issue, Sinha et al. (2011)
now provide evidence that caveolae allowcells to rapidly compensate for changes in
membrane tension.
These findings build on the theoretical
work of Sens and Turner (2006), who
proposed that membrane budding driven
by protein coats (such as observed in
stable caveolae) could constitute a
membrane reservoir that is controlled by
membrane tension (Figure 1). This, in
turn, would impose an equilibrium tension
regulated by the mechanical properties of
these budded domains. Several simple
predictions emanating from this analysis
have provided the motivation behind the
work of Sinha et al., who have directly
investigated the role of budded caveolar
domains as buffers of membrane tension.
The authors measured membrane
tension using a membrane tether-pulling
assay (Sheetz, 2001) while subjecting
cells to a variety of means of altering
membrane area, from osmotic swelling
to elegant micromechanical devices
specially designed for this study. Their
findings show that it is indeed the budded
profile of caveolar domains that act as
reservoirs of membrane area, buffering
against instantaneous changes in mem-
brane tension. Sinha et al. further find
that the role of preformed caveolae in
buffering tension is a passive one; buff-
ering of membrane tension occurs inATP-depleted cells as well as in plasma
membrane spheres detached from other
intramembranous organelles. Whereas
Sens and Turner suggested that the
difference in chemical composition could
drive the formation of budded domains
due to passive budding mechanisms,
Sinha et al. find that this is not altogether
true in living cells. They make an impor-
tant but unexpected discovery that the
regeneration of caveolae during recovery
from osmotic swelling or from the
imposed physical perturbation requires
ATP and is regulated by actin-based
processes.
To establish a potential pathophysio-
logical consequence of disrupting caveo-
lae, the authors show that a mutation in
caveolin 3 (P28L) associatedwith a familial
form of muscular dystrophy called hyper-
CKaemia (FHCK) (Woodman et al., 2004)
prevents the reformation of caveolae
and the buffering of membrane tension.
Although it is not known whether this
form of muscular dystrophy is associated
with increased membrane damage, such
a mechanism for buffering against
changes in membrane tension could be
important for maintaining the integrity of
muscles subject to continuous cycles of
stretching and relaxation. In addition to
muscle fibers, this newly discovered role, February 4, 2011 ª2011 Elsevier Inc. 323
